Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


VALUE AND LIMITATIONS OF CUTTING-EDGE SCIENCE (E.G, PHARMACOGENOMICS AND POPULATION PHARMACODYNAMIC ANALYSIS) TO PATIENT CARE HERE AND NOW

  • In: A2 - Scientific evidence and evidence-based practice (EBP): scope and limitations on Wednesday, 30 September 2015, 14:30-17:30
  • At: Düsseldorf (Germany) (2015)
  • Type: Presentation
  • By: IEIRI, Ichiro (Kyushu University, Clinical Pharmacokinetics, Fukuoka, Japan)
  • Co-author(s): Ichiro Ieiri
  • Abstract:

    In my presentation, I will talk about utility of cutting-edge science, such as pharmacogenomic (PGx) information and population pharmacodynamic (PPD) analysis, at patient care. Currently in Japan, PGx is incorporated into patient care; for example, highly advanced medical treatment (HAMT). The HAMT is the Japanese medical system to provide high

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses